Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regulus Therapeutics | RGLS | Sep 24, 2024 | 1.55 | -5.78 |
Reinsurance Group of America | RGA | Sep 24, 2024 | 219.38 | -0.40 |
REIT Index ETF Vanguard | VNQ | Sep 24, 2024 | 98.90 | +0.14 |
Reitar Logtech | RITR | Sep 24, 2024 | 4.38 | 0.00 |
Rekor Systems | REKR | Sep 24, 2024 | 1.21 | +0.83 |
Relay Therapeutics | RLAY | Sep 24, 2024 | 7.29 | -1.88 |
Reliance | RS | Sep 24, 2024 | 289.42 | +2.01 |
Reliance Global | RELI | Sep 24, 2024 | 2.31 | -3.35 |
Relmada Therapeutics | RLMD | Sep 24, 2024 | 3.46 | -1.14 |
RELX ADR | RELX | Sep 24, 2024 | 48.53 | -0.68 |
Remitly Global | RELY | Sep 24, 2024 | 13.78 | -1.57 |
Renaissance Ipo ETF | IPO | Sep 24, 2024 | 43.29 | +0.44 |
RenaissanceRe | RNR | Sep 24, 2024 | 262.64 | -0.72 |
RenaissanceRe G Pref | RNR-G | Sep 24, 2024 | 18.83 | +0.16 |
RenaissanceRe Holding F Pref | RNR-F | Sep 24, 2024 | 24.98 | +0.32 |
Renalytix ADR | RNLX | Sep 24, 2024 | 0.28 | +7.54 |
Renasant | RNST | Sep 24, 2024 | 32.57 | -1.78 |
Reneo Pharmaceuticals | RPHM | Sep 24, 2024 | 1.41 | +2.17 |
ReNew Energy Global A Shares | RNW | Sep 24, 2024 | 6.62 | +0.61 |
Renn Fund | RCG | Sep 24, 2024 | 2.06 | +0.98 |
Renovaro Biosciences | RENB | Sep 24, 2024 | 0.48 | -5.28 |
RenovoRx | RNXT | Sep 24, 2024 | 1.02 | -0.97 |
Rent The Runway A | RENT | Sep 24, 2024 | 9.63 | +1.90 |
Rentokil Initial ADR | RTO | Sep 24, 2024 | 24.55 | +0.95 |
Repare Therapeutics | RPTX | Sep 24, 2024 | 3.37 | -0.30 |
Repay A | RPAY | Sep 24, 2024 | 8.34 | -2.34 |
Repligen | RGEN | Sep 24, 2024 | 142.85 | +1.72 |
Replimune Group | REPL | Sep 24, 2024 | 11.07 | +1.00 |
ReposiTrak | TRAK | Sep 24, 2024 | 19.56 | +0.36 |
Republic Bancorp A | RBCAA | Sep 24, 2024 | 63.82 | -1.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.